Zimbabwe’s healthcare system is already fragile, overstretched and underfunded. Public hospitals face chronic shortages, long waiting times and recurring industrial unrest. In that environment, any policy affecting healthcare financing should be judged by one simple test: will it expand access to care, or reduce it?

That is why the Ministry of Health and Child Care’s proposed amendments to Statutory Instrument 330 of 2000 (Medical Aid Societies Regulations) deserve urgent and rigorous scrutiny.

At the centre of the debate is a proposed restriction on vertical integration — the ownership or operation by medical aid societies of clinics, hospitals, pharmacies, laboratories and other facilities linked to patient care.

The Ministry argues this is necessary to prevent conflicts of interest. That concern may be legitimate. But the solution must be proportionate, evidence-based and mindful of unintended consequences.

When properly regulated, vertical integration can lower costs, improve continuity of care, shorten referral times, strengthen quality control and expand treatment access. In many health systems, integrated models are used precisely because they improve efficiency and patient outcomes.

Zimbabwe should not dismantle functioning healthcare capacity in pursuit of poorly designed reform. Furthermore, competition and perceived conflicts of interest cannot be addressed in a fragmented sector centric approach when there are specific competition regulations that are overseen by a dedicated commission.

Keep Reading

If implemented in blunt form, the proposed amendments to SI 330 could damage jobs, weaken investment confidence, raise healthcare costs and place further pressure on an already strained public system.

The employment risk is immediate.

The medical aid ecosystem supports nurses, pharmacists, doctors, administrators, technicians, drivers and many others. Industry estimates suggest more than 10,000 jobs could be at risk if societies are forced into hurried disposals, restructuring or closure of service units.

At a time when Zimbabwe needs formal employment growth, not contraction, policymakers should proceed cautiously.

The investment risk is equally serious.

Medical aid societies and associated entities have invested heavily over many years in clinics, pharmacies, laboratories, specialist centres and healthcare infrastructure. Estimates place that value at more than US$200 million.

These are not abstract balance-sheet figures. They are treatment rooms, hospital beds, scanners, pharmacies and diagnostic centres serving real patients every day.

If productive assets can be undermined by abrupt regulatory shifts, investors notice. Zimbabwe cannot invite investment with one hand while creating uncertainty with the other.

The affordability risk may be felt fastest by ordinary citizens.

Many societies moved into service provision because fragmented private markets often produced rising costs, inconsistent pricing and unreliable access. Vertical integration created cost discipline and service continuity for members.

Remove that model overnight, and societies may be forced back into being passive buyers in expensive private markets. The likely result is higher tariffs, more co-payments, reduced benefits and fewer affordable options.

For a teacher, nurse, civil servant or pensioner already under financial strain, higher co-payments are not theoretical. They can mean delayed treatment, skipped medication or going without care altogether.

There is the wider system risk.

If private medical aid becomes weaker or more expensive, more Zimbabweans will drift back into already strained public hospitals. That means longer queues, heavier medicine demand and deeper pressure on taxpayers.

There is a constitutional dimension.

Zimbabwe’s Constitution protects property rights, administrative justice and the right to healthcare. Any intervention that compels disposal of lawfully acquired assets without adequate fairness, due process or proportionality raises serious legal questions.

Government has every right to regulate. But regulation should be targeted and intelligent. In this case, such regulation should be in the form of patient centered policies. So far, in the ongoing debate, nothing suggests that the proposed amendment is aimed at enhancing patient access, care and health outcomes.

If conflicts of interest exist, smarter remedies are available:

  • stronger governance safeguards within integrated healthcare structures
  • * transparent pricing and disclosure rules

* independent audits and competition oversight

* consumer protection enforcement

* quality regulation

These measures address abuse without destroying capacity.

This is where Parliament must play its oversight role.

Legislators are entrusted to protect the public interest, test policy assumptions and prevent avoidable economic harm. They must rigorously examine whether these proposed amendments protect or endanger jobs, patients, investment and healthcare access.

This is the real policy choice: reform with precision, or regulate with a sledgehammer.

Zimbabwe needs every clinic bed, pharmacy shelf, diagnostic machine and healthcare worker it can retain. The goal should not be to weaken medical aid societies, but to make them more transparent, accountable and efficient while preserving their contribution to national healthcare delivery. In any event, what are medical aids? Are they not a vehicle through which a collective group of subscribers are coming together to guarantee their own access to healthcare as and when they need it? So, where are those subscribers’ interests in this debate?

Zimbabwe still has time to reform wisely. But once jobs are lost, investments unwind and healthcare capacity disappears, rebuilding it will be far harder. The one question that should exercise the regulators’ mind is this: which part of these proposed reforms are in the best interests of the patients, and how?
Previous article
SI 330 Threatens Jobs, Investment and Patient Care
Next article
12-hour queues as boreholes dry up